Restless legs syndrome.

Full Abstract

Restless legs syndrome (RLS) affects many people. General population prevalence surveys usually range from 1% to 12%, but most European ancestry studies suggest 10%. The development of validated rating scales and standardized diagnostic criteria have vastly improved the quality of RLS treatment trials. Although multiple medications have shown outstanding efficacy, all of them are felt to provide only symptomatic relief, rather than any "curative" effect. Dopamine agonists are clearly the best investigated and probably the most effective treatments for RLS.

Author information

Author/s: Ondo, William G (WG);

Affiliation: Department of Neurology, Baylor College of Medicine, Houston, TX, USA. hwondo(-atsign-)bcm.tmc.edu

Journal and publication information

Publication Type: Journal Article; Review

Journal: Neurologic clinics (Neurol Clin), published in United States. (Language: eng)

Reference: 2009-Aug; vol 27 (issue 3) : pp 779-99, vii

Dates: Created 2009/06/26; Completed 2009/09/14;

PMID: 19555831, status: MEDLINE (last retrieved date: 9/14/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.